Vijaypd Ceutical (NSE:VIJAYPD) ROE %: 28.91% (As of Mar. 2025) — Near Median


NSE:VIJAYPD Vijaypd Ceutical Ltd NSE:VIJAYPD
14 GF Score
Price ₹80.75
! 2 Warning Signs
View Full Analysis

What is Vijaypd Ceutical ROE %?

Vijaypd Ceutical NSE:VIJAYPD -4.94% 14 ROE % is 28.91% as of Mar. 2025, which is at its 10-year median of 28.91. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Vijaypd Ceutical ranks better than 91.37% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Vijaypd Ceutical's annualized net income for the quarter that ended in Mar. 2025 was ₹48 Mil. Vijaypd Ceutical's average Total Stockholders Equity over the quarter that ended in Mar. 2025 was ₹166 Mil. Therefore, Vijaypd Ceutical's annualized ROE % for the quarter that ended in Mar. 2025 was 28.91%.

The historical rank and industry rank for Vijaypd Ceutical's ROE % or its related term are showing as below:

NSE:VIJAYPD' s ROE % Range Over the Past 10 Years
Min: 3.68   Med: 28.91   Max: 55.64
Current: 28.91

During the past 3 years, Vijaypd Ceutical's highest ROE % was 55.64%. The lowest was 3.68%. And the median was 28.91%.

NSE:VIJAYPD's ROE % is ranked better than
91.37% of 626 companies
in the Healthcare Providers & Services industry
Industry Median: 5.805 vs NSE:VIJAYPD: 28.91

Vijaypd Ceutical  (NSE:VIJAYPD) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2025 )
=Net Income/Total Stockholders Equity
=47.955/165.849
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(47.955 / 1068.069)*(1068.069 / 452.1015)*(452.1015 / 165.849)
=Net Margin %*Asset Turnover*Equity Multiplier
=4.49 %*2.3625*2.726
=ROA %*Equity Multiplier
=10.61 %*2.726
=28.91 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2025 )
=Net Income/Total Stockholders Equity
=47.955/165.849
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (47.955 / 65.219) * (65.219 / 79.217) * (79.217 / 1068.069) * (1068.069 / 452.1015) * (452.1015 / 165.849)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7353 * 0.8233 * 7.42 % * 2.3625 * 2.726
=28.91 %

Note: The net income data used here is one times the annual (Mar. 2025) net income data. The Revenue data used here is one times the annual (Mar. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Vijaypd Ceutical ROE % Related Terms


Vijaypd Ceutical ROE % Historical Data

* Premium members only.

The historical data trend for Vijaypd Ceutical's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vijaypd Ceutical ROE % Chart

Vijaypd Ceutical Annual Data
Trend Mar23 Mar24 Mar25
ROE %
3.68 55.64 28.91

Vijaypd Ceutical Semi-Annual Data
Mar23 Mar24 Mar25
ROE % 3.68 55.64 28.91

Vijaypd Ceutical ROE % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vijaypd Ceutical ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's ROE % distribution charts can be found below:

* The bar in red indicates where Vijaypd Ceutical's ROE % falls into.


NSE:VIJAYPD
14GF Score
Vijaypd Ceutical Ltd NSE:VIJAYPD
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vijaypd Ceutical ROE % Calculation

Vijaypd Ceutical's annualized ROE % for the fiscal year that ended in Mar. 2025 is calculated as

ROE %=Net Income (A: Mar. 2025 )/( (Total Stockholders Equity (A: Mar. 2024 )+Total Stockholders Equity (A: Mar. 2025 ))/ count )
=47.955/( (10+321.698)/ 2 )
=47.955/165.849
=28.91 %

Vijaypd Ceutical's annualized ROE % for the quarter that ended in Mar. 2025 is calculated as

ROE %=Net Income (Q: Mar. 2025 )/( (Total Stockholders Equity (Q: Mar. 2024 )+Total Stockholders Equity (Q: Mar. 2025 ))/ count )
=47.955/( (10+321.698)/ 2 )
=47.955/165.849
=28.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Mar. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 28.91% mean?
Vijaypd Ceutical (NSE:VIJAYPD) has a ROE % of 28.91% as of Mar. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vijaypd Ceutical and its competitors. This is near median its historical median of 28.91. Over the past decade, Vijaypd Ceutical's ROE % has ranged from 3.68 to 55.64. According to the industry distribution chart, Vijaypd Ceutical ranks #54 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 8.6%.
Is Vijaypd Ceutical's ROE % too high?
Vijaypd Ceutical's current ROE % of 28.91% is near median its 10-year median of 28.91. Over the past 10 years, this metric has ranged from a low of 3.68 to a high of 55.64. The Healthcare Providers & Services industry median ROE % is 5.81. Vijaypd Ceutical's value of 28.91% is 398% above this industry median. Based on the distribution chart, Vijaypd Ceutical ranks #54 out of 626 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaypd Ceutical has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's ROE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #54 out of 626 companies for ROE %. This places Vijaypd Ceutical in the top 9% of its industry — outperforming the majority of peers. The industry median ROE % is 5.81. Vijaypd Ceutical's value of 28.91% is 398% above this benchmark. Historically, Vijaypd Ceutical's own ROE % has ranged from 3.68 to 55.64 over the past decade. While the company's 10-year median is 28.91 vs. the industry median of 5.81, Vijaypd Ceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaypd Ceutical's current ROE % of 28.91% is 398% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current ROE % is 28.91%, which is near median its own 10-year median of 28.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current ROE % of 28.91%. The current ROE % is 28.91%, which is near median its 10-year median of 28.91 and 398% above the Healthcare Providers & Services industry median of 5.81. Vijaypd Ceutical's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current ROE % is 28.91% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vijaypd Ceutical Business Description

Address A/1, 1st Floor, Devraj Premises, CHSL, Goregaon West, Mumbai, MH, IND, 400062
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
14GF Score

Get the complete analysis for NSE:VIJAYPD

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹80.75
Price